Stilbenes: Chemistry and Molecular Mechanisms of Anti-obesity
Current Pharmacology Reports - 2018
Tóm tắt
Stilbenoids, a class of plant polyphenols abundant in berries, have been found to have many biological actions. Resveratrol, the most well-known of the stilbenes, is used for disease prevention, particularly for anti-obesity. Due to the low bioavailability of resveratrol, other stilbenes and their metabolites are also considered as candidates for anti-obesity. Obesity has numerous known causes, including genetics, diet, lifestyle, the endocrine system, and gut microbiota. Treating obesity can be rather problematic, with calorie intake reductions and increased physical exercise being difficult to maintain, medicines having side effects, and surgery being not suitable for all patients. Many stilbenes tested in animal studies have demonstrated beneficial effects, including reductions of lipid accumulation, regulation of glucose homeostasis, inflammation alleviation, and modulation of gut microbiota. This paper summarizes the molecular mechanisms of four major stilbenes used to treat obesity. Several pathways involved in regulation of fat metabolism affected by stilbenes, such as adipogenesis, lipogenesis, lipolysis, thermogenesis, and gut microbiota, will be introduced. In summary, stilbenes are promising for managing and treating obesity. A comparison of the physiological effects of various stilbenoids and other stilbene derivatives on obesity-associated diseases is warranted.
Từ khóa
Tài liệu tham khảo
Jeandet P, Delaunois B, Conreux A, Donnez D, Nuzzo V, Cordelier S, et al. Biosynthesis, metabolism, molecular engineering, and biological functions of stilbene phytoalexins in plants. Biofactors. 2010;36(5):331–41.
Tsai H-Y, Ho C-T, Chen Y-K. Biological actions and molecular effects of resveratrol, pterostilbene, and 3′-hydroxypterostilbene. J Food Drug Anal. 2017;25(1):134–47.
Dvorakova M, Landa P. Anti-inflammatory activity of natural stilbenoids: a review. Pharmacol Res. 2017;124:126–45.
Aguirre L, Fernandez-Quintela A, Arias N, Portillo MP. Resveratrol: anti-obesity mechanisms of action. Molecules. 2014;19(11):18632–55.
Pan M-H, Wu J-C, Ho C-T, Lai C-S. Antiobesity molecular mechanisms of action: resveratrol and pterostilbene. BioFactors.
Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377–82.
Knight JA. Diseases and disorders associated with excess body weight. Annals of Clinical & Laboratory Science. 2011;41(2):107–121.
Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care. 2005;28(9):2322–5.
Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front Endocrinol (Lausanne). 2016;7:30.
Esteve Rafols M. Adipose tissue: cell heterogeneity and functional diversity. Endocrinol Nutr. 2014;61(2):100–12.
Tang QQ, Otto TC, Lane MD. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci U S A. 2003;100(1):44–9.
Rosen ED, Hsu C-H, Wang X, Sakai S, Freeman MW, Gonzalez FJ, et al. C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev. 2002;16(1):22–6.
Wang Y, Jones Voy B, Urs S, Kim S, Soltani-Bejnood M, Quigley N, et al. The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. J Nutr. 2004;134(5):1032–8.
Ladeira M, Schoonmaker J, Gionbelli M, Dias J, Gionbelli T, Carvalho J, et al. Nutrigenomics and beef quality: a review about lipogenesis. Int J Mol Sci. 2016;17(6):918.
Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr. 2007;27:79–101.
Sanchez-Gurmaches J, Hung C-M, Guertin DA. Emerging complexities in adipocyte origins and identity. Trends in Cell Biol. 26(5):313–26.
Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol. 2014;10(1):24–36.
Gleyzer N, Vercauteren K, Scarpulla RC. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol. 2005;25(4):1354–66.
Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718–23.
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3.
Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001;121(3):580–91.
Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem. 2004;52(15):4713–9.
Chen S, Xiao X, Feng X, Li W, Zhou N, Zheng L, et al. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression. J Nutr Biochem. 2012;23(9):1100–12.
Kwon JY, Seo SG, Yue S, Cheng J-X, Lee KW, Kim K-H. An inhibitory effect of resveratrol in the mitotic clonal expansion and insulin signaling pathway in the early phase of adipogenesis. Nutr Res. 2012;32(8):607–16.
Lasa A, Schweiger M, Kotzbeck P, Churruca I, Simón E, Zechner R, et al. Resveratrol regulates lipolysis via adipose triglyceride lipase. J Nutr Biochem. 2012;23(4):379–84.
Li S, Bouzar C, Cottet-Rousselle C, Zagotta I, Lamarche F, Wabitsch M, et al. Resveratrol inhibits lipogenesis of 3T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 2016;1857(6):643–52.
Kim S, Jin Y, Choi Y, Park T. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol. 2011;81(11):1343–51.
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell. 2006;127(6):1109–22.
Wang S, Liang X, Yang Q, Fu X, Rogers CJ, Zhu M, et al. Resveratrol induces brown-like adipocyte formation in white fat through activation of AMP-activated protein kinase (AMPK) alpha1. Int J Obes (2005). 2015;39(6):967–76.
Qiao Y, Sun J, Xia S, Tang X, Shi Y, Le G. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct. 2014;5(6):1241–9. https://doi.org/10.1039/c3fo60630a.
Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, et al. High-dose resveratrol supplementation in obese men. an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes. 2013;62(4):1186–95.
Asensi M, Medina I, Ortega A, Carretero J, Baño MC, Obrador E, et al. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med. 2002;33(3):387–98.
Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res. 2005;49(5):472–81.
Lasa A, Churruca I, Eseberri I, Andres-Lacueva C, Portillo MP. Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Mol Nutr Food Res. 2012;56(10):1559–68.
Eseberri I, Lasa A, Churruca I, Portillo MP. Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes. PLoS One. 2013;8(5):e63918.
Böhmdorfer M, Szakmary A, Schiestl R, Vaquero J, Riha J, Brenner S, et al. Involvement of UDP-glucuronosyltransferases and sulfotransferases in the excretion and tissue distribution of resveratrol in mice. Nutrients. 2017;9(12):1347.
Zhou J, Li S-x, Wang W, X-y G, X-y L, X-p Y, et al. Variations in the levels of mulberroside A, oxyresveratrol, and resveratrol in mulberries in different seasons and during growth. Sci World J. 2013;2013:1–7.
Maneechai S, Likhitwitayawuid K, Sritularak B, Palanuvej C, Ruangrungsi N, Sirisa-Ard P. Quantitative analysis of oxyresveratrol content in Artocarpus lakoocha and ‘Puag-Haad’. Med Princ Pract. 2009;18(3):223–7.
Tan H-Y, Tse IMY, Li ETS, Wang M. Inhibitory effects of oxyresveratrol and cyanomaclurin on adipogenesis of 3T3-L1 cells. J Funct Foods. 2015;15:207–16.
Tan HY, Tse IM, Li ET, Wang M. Oxyresveratrol supplementation to C57bl/6 mice fed with a high-fat diet ameliorates obesity-associated symptoms. Nutrients. 2017;9(2) https://doi.org/10.3390/nu9020147.
Li F, Sun Y, Song M, Wu X, Xiao H. Gastrointestinal biotransformation of resveratrol in mice. FASEB J. 2016;30:145.7–.7.
Kwon JY, Seo SG, Heo YS, Yue S, Cheng JX, Lee KW, et al. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J Biol Chem. 2012;287(14):11566–78.
Uchida-Maruki H, Inagaki H, Ito R, Kurita I, Sai M, Ito T. Piceatannol lowers the blood glucose level in diabetic mice. Biol Pharm Bull. 2015;38(4):629–33.
Tung YC, Lin YH, Chen HJ, Chou SC, Cheng AC, Kalyanam N, et al. Piceatannol exerts anti-obesity effects in C57BL/6 mice through modulating adipogenic proteins and gut microbiota. Mol (Basel, Switzerland). 2016;21(11)
Yamamoto T, Li Y, Hanafusa Y, Yeh YS, Maruki-Uchida H, Kawakami S, et al. Piceatannol exhibits anti-inflammatory effects on macrophages interacting with adipocytes. Food Sci Nutr. 2017;5(1):76–85.
Li Y, Yang P, Chang Q, Wang J, Liu J, Lv Y, et al. Inhibitory effect of piceatannol on TNF-α mediated inflammation and insulin resistance in 3T3-L1 adipocytes. J Agric Food Chem. 2017;
Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol. 2011;68(3):593–601.
Seo YJ, Kim KJ, Koh EJ, Choi J, Lee BY. Anti-adipogenesis mechanism of pterostilbene through the activation of heme oxygenase-1 in 3T3-L1 cells. Phytomedicine. 2017;33:7–13.
Nagao K, Jinnouchi T, Kai S, Yanagita T. Pterostilbene, a dimethylated analog of resveratrol, promotes energy metabolism in obese rats. J Nutr Biochem. 2017;43:151–5.
Aguirre L, Milton-Laskibar I, Hijona E, Bujanda L, Rimando AM, Portillo MP. Effects of pterostilbene in brown adipose tissue from obese rats. J Physiol Biochem. 2016;73(3):457–64.
Etxeberria U, Hijona E, Aguirre L, Milagro FI, Bujanda L, Rimando AM, et al. Pterostilbene-induced changes in gut microbiota composition in relation to obesity. Mol Nutr Food Res. 2017;61(1).